ADAM17 and pancreatic adenocarcinoma: In conclusion, hypomethylation of ADAM17 was positively correlated with high ADAM17 expression in PAAD tumor tissues, suggesting that hypomethylation of the ADAM17 promoter may be responsible for the increased ADAM17 expression in PAAD tissues.